Choline salicylate 870 mg / dextromethorphan HBr 20 mg / guaiFENesin 200 mg in 30 mL Oral Solution
RxNorm 2670541
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2670541 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: choline salicylate 870 mg / dextromethorphan HBr 20 mg / guaiFENesin 200 mg in 30 mL Oral Solution.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCD
Semantic Clinical Drug (SCD):
Choline salicylate 29 mg/ML / dextromethorphan hydrobromide 0.667 mg/ML / guaifenesin 6.67 mg/ML Oral Solution
(Atom ID: 12863833)
TMSY
Tall Man Lettering Synonym (TMSY):
Choline salicylate 29 mg/ML / dextromethorphan hydrobromide 0.667 mg/ML / guaiFENesin 6.67 mg/ML Oral Solution
(Atom ID: 12863988)
PSN
Prescribable Name (PSN):
Choline salicylate 870 mg / dextromethorphan HBr 20 mg / guaiFENesin 200 mg in 30 mL Oral Solution
(Atom ID: 12863972)
SY
Synonym (SY):
Choline salicylate 870 mg / dextromethorphan HBr 20 mg / guaifenesin 200 mg per 30 mL Oral Solution
(Atom ID: 12863834)
TMSY